Diabetes complications

Clinical utility of novel diabetes subgroups in predicting vascular complications and mortality: up to 25 years of follow-up of the HUNT Study

BMJ Open Diabetes Res CarePublished Population-based cohort study

Authors' conclusion

Cluster assignment did not provide better prediction of vascular complications or all-cause mortality compared with established risk factors.

Study context

Population
Adults with adult-onset diabetes from HUNT2 (1995–1997) and HUNT3 (2006–2008), Norwegian Trøndelag Health Study
Participants
1,899 adults
Exposure
Diabetes cluster assignment vs established risk factors for predicting vascular complications and mortality
Outcome
Predictive ability (C-index, R2) of clusters vs established risk factors for vascular complications and all-cause mortality
Follow-up
Median 9-13 years
Methodological detailsdata-driven cluster analysis, Cox proportional hazards models, C-index and R2 prediction comparison
  • Data-driven cluster analysis
  • Cox proportional hazards models
  • C-index and R2 prediction comparison

Main finding

As reported in the abstract

Predictive ability of clusters vs established risk factors
Retinopathy C-index: clusters
0.65 (95% CI 0.63 to 0.68)
Retinopathy C-index: HbA1c
0.65 (95% CI 0.63 to 0.68)
Retinopathy C-index: fasting C-peptide
0.66 (95% CI 0.63 to 0.68)
CKD C-index: clusters
0.74 (95% CI 0.72 to 0.76)
CKD C-index: TG/HDL ratio
0.74 (95% CI 0.71 to 0.76)
CKD C-index: fasting C-peptide
0.74 (95% CI 0.72 to 0.76)
CKD C-index: baseline eGFR
0.76 (95% CI 0.74 to 0.78)

Observational data: associations, not effects.

Original publication

Clinical utility of novel diabetes subgroups in predicting vascular complications and mortality: up to 25 years of follow-up of the HUNT Study. BMJ Open Diabetes Res Care. Published 21 November 2024. doi:10.1136/bmjdrc-2024-004493

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.